Browse by Research Project Code

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Delles, C. et al. (2017) Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. European Journal of Heart Failure, (doi:10.1002/ejhf.1076) (PMID:29226610) (Early Online Publication)

Rodie, M.E., Mudaliar, M.A.V. , Herzyk, P., McMillan, M., Boroujerdi, M., Chudleigh, S., Tobias, E.S. and Ahmed, S.F. (2017) Androgen-responsive non-coding small RNAs extend the potential of HCG stimulation to act as a bioassay of androgen sufficiency. European Journal of Endocrinology, 177(4), pp. 339-346. (doi:10.1530/EJE-17-0404) (PMID:28733293)

Nixon, R., Cerqueira, V., Kyriakou, A., Lucas-Herald, A., McNeilly, J., McMillan, M., Purvis, A., Tobias, E.S., McGowan, R. and Ahmed, S.F. (2017) Prevalence of endocrine and genetic abnormalities in boys evaluated systematically for a disorder of sex development. Human Reproduction, 32(10), pp. 2130-2137. (doi:10.1093/humrep/dex280) (PMID:28938747)

Cooke, S. L. et al. (2017) The driver mutational landscape of ovarian squamous cell carcinomas arising in mature cystic teratoma. Clinical Cancer Research, (doi:10.1158/1078-0432.CCR-17-1789) (PMID:28954785) (Early Online Publication)

Babic, A. et al. (2017) Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium. Cancer Causes and Control, 28(5), pp. 459-468. (doi:10.1007/s10552-016-0841-3) (PMID:28050675)

Dominiczak, A. , Delles, C. and Padmanabhan, S. (2017) Genomics and precision medicine for clinicians and scientists in hypertension. Hypertension, 69(4), e10-e13. (doi:10.1161/HYPERTENSIONAHA.116.08252) (PMID:28193712)

Maclay, J. D., Farley, J. M.B., McCowan, C. , Tweed, C. and Milroy, R. (2017) Obtaining tissue diagnosis in lung cancer patients with poor performance status and its influence on treatment and survival. Respiratory Medicine, 124, pp. 30-35. (doi:10.1016/j.rmed.2017.01.002)

Al-Rawhani, M. A. et al. (2017) A colorimetric CMOS-based platform for rapid total serum cholesterol quantification. IEEE Sensors Journal, 17(2), pp. 240-247. (doi:10.1109/JSEN.2016.2629018)

Salvi, E. et al. (2017) Genome-wide and gene-based meta-analyses identify novel loci influencing blood pressure response to hydrochlorothiazide. Hypertension, 69(1), pp. 51-59. (doi:10.1161/HYPERTENSIONAHA.116.08267) (PMID:27802415)

Preiss, D. and Sattar, N. (2016) Research digest: cardiac biomarkers for risk prediction. Lancet Diabetes and Endocrinology, 4(11), p. 890. (doi:10.1016/S2213-8587(16)30293-5) (PMID:27743976)

Zhu, A. X. et al. (2016) Biomarker analyses of clinical outcomes in patients with advanced hepatocellular carcinoma treated with Sorafenib with or without Erlotinib in the SEARCH Trial. Clinical Cancer Research, 22(19), pp. 4870-4879. (doi:10.1158/1078-0432.CCR-15-2883) (PMID:27220960)

Ehret, G. B. et al. (2016) The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nature Genetics, 48(10), pp. 1171-1184. (doi:10.1038/ng.3667) (PMID:27618452) (PMCID:PMC5042863)

Kar, S. P. et al. (2016) Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types. Cancer Discovery, 6(9), pp. 1052-1067. (doi:10.1158/2159-8290.CD-15-1227) (PMID:27432226) (PMCID:PMC5010513)

Hoogendoorn, M. et al. (2016) Patient heterogeneity in health economic decision models for chronic obstructive pulmonary disease: are current models suitable to evaluate personalized medicine? Value in Health, 19(6), pp. 800-810. (doi:10.1016/j.jval.2016.04.002) (PMID:27712708)

Van Der Hooft, J., Padmanabhan, S. , Burgess, K. and Barrett, M. (2016) Erratum to: Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentation. Metabolomics, 12(8), 139. (doi:10.1007/s11306-016-1078-6)

Swanton, C. et al. (2016) Consensus on precision medicine for metastatic cancers: a report from the MAP conference. Annals of Oncology, 27(8), pp. 1443-1448. (doi:10.1093/annonc/mdw192) (PMID:27143638)

McNeish, I. A. (2016) Prognostic pathways in early-stage ovarian cancer: can gene expression transcend histological subtype? Annals of Oncology, 27(8), pp. 1366-1368. (doi:10.1093/annonc/mdw254) (PMID:27358384)

Van Der Hooft, J. J.J., Padmanabhan, S. , Burgess, K. E.V. and Barrett, M. P. (2016) Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentation. Metabolomics, 12, 125. (doi:10.1007/s11306-016-1064-z) (PMID:27471437) (PMCID:PMC4932139)

Porter, D. et al. (2016) Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial. Lancet, 388(10041), pp. 239-247. (doi:10.1016/S0140-6736(16)00380-9) (PMID:27197690)

Poortvliet, R. K.E. et al. (2016) Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: additive value of N-terminal pro-B-type natriuretic peptide. European Journal of Preventive Cardiology, 23(10), pp. 1104-1113. (doi:10.1177/2047487315617908) (PMID:26603744)

Sattar, N. and Preiss, D. (2016) Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. Lancet Diabetes and Endocrinology, 4(7), pp. 555-556. (doi:10.1016/s2213-8587(16)30097-3) (PMID:27216887)

Cheah, B. C. , MacDonald, A. I., Martin, C., Streklas, A. J., Campbell, G., Al-Rawhani, M. A., Nemeth, B., Grant, J. P. , Barrett, M. P. and Cumming, D. R.S. (2016) An integrated circuit for chip-based analysis of enzyme kinetics and metabolite quantification. IEEE Transactions on Biomedical Circuits and Systems, 10(3), pp. 721-730. (doi:10.1109/TBCAS.2015.2487603) (PMID:26742138)

Kleeff, J. et al. (2016) Pancreatic cancer. Nature Reviews Disease Primers, 2, 16022. (doi:10.1038/nrdp.2016.22) (PMID:27158978)

Neisius, U. et al. (2016) Urine proteomics in the diagnosis of stable angina. BMC Cardiovascular Disorders, 16, 70. (doi:10.1186/s12872-016-0246-y) (PMID:27095611) (PMCID:PMC483761)

Stitziel, N. O. et al. (2016) Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. New England Journal of Medicine, 374(12), pp. 1134-1144. (doi:10.1056/NEJMoa1507652) (PMID:26934567) (PMCID:PMC4850838)

Bailey, P. et al. (2016) Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), pp. 47-52. (doi:10.1038/nature16965) (PMID:26909576)

Rahbari, R. et al. (2016) Timing, rates and spectra of human germline mutation. Nature Genetics, 48(2), pp. 126-133. (doi:10.1038/ng.3469) (PMID:26656846) (PMCID:PMC4731925)

Meeks, H. D. et al. (2016) BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers. Journal of the National Cancer Institute, 108(2), djv315. (doi:10.1093/jnci/djv315) (PMID:26586665) (PMCID:PMC4907358)

Henry, S. L., Withers, J. M., Singh, I., Cooper, J. M. , Clark, A. W., Burley, G. A. and Cogdell, R. J. (2016) DNA-directed spatial assembly of photosynthetic light-harvesting proteins. Organic and Biomolecular Chemistry, 14(4), pp. 1359-1362. (doi:10.1039/c5ob02351c) (PMID:26660647)

Johnatty, S. E. et al. (2015) Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research, 21(23), pp. 5264-5276. (doi:10.1158/1078-0432.CCR-15-0632) (PMID:26152742) (PMCID:PMC4624261)

This list was generated on Wed Jan 17 18:56:41 2018 GMT.